BURLINGTON, Mass., April 22, 2014 /PRNewswire/ -- Putnam Associates, a premier strategy consulting firm dedicated to serving the life sciences industry, announced that Jonathan Hodgson has recently joined the firm as Principal. In his role in the expanding leadership team, Jonathan will help drive the continued growth of the firm's New Products Strategy and Pricing, Reimbursement & Market Access practices.
"Jonathan brings a unique combination of business acumen and an extensive background in modeling and valuation," said Remco op den Kelder, Partner and Boston Office Head. "He is a valuable addition to our growing firm and I am confident he has the experience and leadership to continue Putnam's tradition of working collaboratively with our clients and providing insights to drive strategies for today's increasingly global and complex biopharmaceutical business environment."
Jonathan has more than 10 years of experience helping biopharmaceutical companies make better strategic decisions. He has worked with clients on commercialization strategy, R&D strategy, portfolio planning, launch pricing and reimbursement, forecasting, asset valuation and other custom assignments across a broad range of therapeutic areas. He brings particularly deep expertise in leveraging innovative methodologies and large data sets to support analysis and decision-making. Before joining Putnam, Jonathan worked as a strategy consultant at L.E.K. and the Amundsen Group. Prior to his consulting career, Jonathan served in several roles at Vertex Pharmaceuticals. Jonathan is co-author of "Biopharma: Beyond the First Product," published in In Vivo, and has lectured on valuation approaches and techniques at the Mass Biotech Council. Jonathan received undergraduate degrees at Dartmouth College and an MBA from Harvard Business School.
About Putnam Associates
Putnam Associates is a premier strategy consulting firm serving biopharmaceutical, diagnostics, medical device clients, and the private capital community. To learn more, visit our website or follow us on LinkedIn.
SOURCE Putnam Associates